Dietary intake of inulin-type fructans in active and inactive Crohn's disease and healthy controls: A case-control study

Journal of Crohn's and Colitis

Volumn 9, Issue 11, 2015, Pages 1024-1031

  Anderson, Jacqueline L ^a   Hedin, Charlotte R ^a   Benjamin, Jane L ^a   Koutsoumpas, Andreas ^a   Ng, Siew C ^b,c   Hart, Ailsa L ^b   Forbes, Alastair ^d   Stagg, Andrew J ^e   Lindsay, James O ^e,f   Whelan, Kevin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

FODMAPs; fructans; Inflammatory bowel disease; inulin; oligofructose

Indexed keywords

FRUCTAN; FRUCTOSE OLIGOSACCHARIDE; INULIN; INULIN TYPE FRUCTAN; UNCLASSIFIED DRUG; OLIGOSACCHARIDE; PREBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; DIETARY INTAKE; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ACTIVITY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HARVEY BRADSHAW INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WELLBEING; ADOLESCENT; DIET; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CROHN DISEASE; DIET; DIET SURVEYS; FEMALE; HUMANS; INULIN; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PREBIOTICS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84963751458     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv136     Document Type: Article

References (42)

1. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014;146:1489-99
2. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94
3. Hedin CR, McCarthy NE, Louis P, et al. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings. Gut 2014;63:1578-86
4. Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 2011;45:S120-7
5. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013;504:451-5
6. Roberfroid M, Gibson GR, Hoyles L, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010;104 Suppl 2:S1-63
7. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009;101:541-50
8. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008;105:16731-6
9. Van Loo J, Coussement P, de Leenheer L, Hoebregs H, Smits G. On the presence of fructan and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr 1995;35:525-52
10. Moshfegh AJ, Friday JE, Goldman JP, Ahuja JK. Presence of fructan and oligofructose in the diets of Americans. J Nutr 1999;129:S1407-11
11. Dunn S, Datta A, Kallis S, Law E, Myers CE, Whelan K. Validation of a food frequency questionnaire to measure intakes of fructan and oligofructose. Eur J Clin Nutr 2011;65:402-8
12. Benjamin JL, Hedin CR, Koutsoumpas A, et al. Randomised, doubleblind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 2011;60:923-9
13. Joossens M, De Preter V, Ballet V, Verbeke K, Rutgeerts P, Vermeire S. Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial. Gut 2012;61:958
14. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012 Oct;107:1474-82
15. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008;6:765-71
16. Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:707-17
17. Prince A, Whelan K, Moosa A, Lomer MC, Reidlinger DP. Nutritional problems in inflammatory bowel disease: the patient perspective. J Crohns Colitis 2011;5:443-50
18. Triggs CM, Munday K, Hu R, et al. Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutat Res 2010;690:123-38
19. Zallot C, Quilliot D, Chevaux JB, et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis 2013;19:66-72
20. Cohen AB, Lee D, Long MD, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci 2013;58:1322-8
21. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514
22. Vermeire S, Schreiber S, Sandborn WJ, Dubois C, Rutgeerts P. Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. Clin Gastroenterol Hepatol 2010;8:357-63
23. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53
24. Food Standards Agency, Mills A, Patel A, Crawley H. Food Portion Sizes. 3rd edn. London: HMSO, 2002
25. Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 2014;8:717-25
26. Lomer MC. Dietary and nutritional considerations for inflammatory bowel disease. Proc Nutr Soc 2011;70:329-35
27. Wedlake L, Slack N, Andreyev HJ, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis 2014 Mar;20:576-86
28. Inns SJ, Emmanuel AV. Survey of UK and New Zealand gastroenterologists' practice regarding dietary advice and food exclusion in irritable bowel syndrome and inflammatory bowel disease. Frontline Gastroenterol 2013;4:44-50
29. Aghdassi E, Wendland BE, Stapleton M, Raman M, Allard JP. Adequacy of nutritional intake in a Canadian population of patients with Crohn's disease. J Am Diet Assoc 2007;107:1575-80
30. Whelan K, Abrahmsohn O, David GJ, et al. Fructan content of commonly consumed wheat, rye and gluten-free breads. Int J Food Sci Nutr 201;62:498-503
31. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 2009;3:8-14
32. Vagianos K, Bector S, McConnell J, Bernstein CN. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007;31:311-9
33. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 2009;30:165-74
34. Lomer MC, Kodjabashia K, Hutchinson C, Greenfield SM, Thompson RP, Powell JJ. Intake of dietary iron is low in patients with Crohn's disease: a case-control study. Br J Nutr 2004;91:141-8
35. Sousa Guerreiro C, Cravo M, Costa AR, et al. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol 2007;102:2551-6
36. Ng SC, Benjamin JL, McCarthy NE, et al. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis 2011;17:2027-37
37. Lee J, Allen R, Ashley S, et al., Gastroenterology Specialist Group of the British Dietetic Association. British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adults. J Hum Nutr Diet 2014;27:207-18
38. Hedin CR, Mullard M, Sharratt E, et al. Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2010;16:2099-108
39. Coyle BL, Sladen GE, Reshef G. Food intake and nutritional status in stable Crohn's disease. J Hum Nutr Diet 1988;1:359-364
40. Bryant RV, Trott MJ, Bartholomeusz FD, Andrews JM. Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2013;38:213-25
41. Muir JG, Rose R, Rosella O, et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by highperformance liquid chromatography (HPLC). J Agric Food Chem 2009;57:554-65
42. Biesiekierski JR, Rosella O, Rose R, et al. Quantification of fructans, galacto-oligosaccharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011;24:154-76